Analysis of national data from the health ministry programme of reduction of the cardiovascular risks (2002-2005) shows a high frequency of cardiovasculor disease and cardiovascular risk factors in the general population. It is of interest to analyse these data in relation to the practice of rheumotology In addition, the frequency of cardiovascular pathologies is higher in patients with rheumatoid arthritis and spondylorthropathy These notions ore also very important since these two populations are often treated with non-steroid(71 anti-inflammatory drugs for a long duration. General knowledge shown in this article concerning the Cardiovascular risk factors and co-morbidities in the patients with rheumatic pathologies allows, within the context of a therapeutic decisionol strategy in rheumotology a better estimation of the individual benefit/risk ratio of each prescription and more particularly that of non-steroidal antiinflammatory drugs.
机构:
Karolinska Univ Hosp, Rheumatol Unit, Dept Med, Karolinska Inst, Stockholm, SwedenKarolinska Univ Hosp, Rheumatol Unit, Dept Med, Karolinska Inst, Stockholm, Sweden
机构:
Joan and Sanford I Weill Medical College of Cornell University, Division of General Internal Medicine, 525 East 68th Street, F-2019, PO Box #331, New York, 10065, NY
Division of Rheumatology, Hospital for Special Surgery, New York, NYUniversity of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, 836 Faculty Office Tower, 510 20th Street South, Birmingham, 35294, AL